From: Description of CRISPR/Cas9 development and its prospect in hepatocellular carcinoma treatment
Category | Description of CRISPR/Cas9 function | Reference |
---|---|---|
Interference in HBV | Edit coding sequence in cccDNA | |
Edit conserved region | ||
Edit HBsAg protein coding sequence | [59] | |
Participate in combination therapy | [60] | |
Manipulate cancer genome | Knock out or insert specific sequence | |
Create hepatocarcinoma mouse model | Knock out specific gene | [62] |
Edit genome in mouse embryonic cells | [63] | |
Enhance immunotherapy | Modify PD-1 of immune cell | |
Modify CAR-T cell | [66] | |
Induce differentiation of iPSCs | [67] | |
Create potential tool applied in human body | Form delivery agent containing target sgRNA | [68] |
Establish CRISPR/Cas9 libraries | Integrate experimental data and prepare for gene screen | [12] |